DK2269589T3 - Ionbindende polymerer og anvendelser deraf - Google Patents

Ionbindende polymerer og anvendelser deraf

Info

Publication number
DK2269589T3
DK2269589T3 DK10186212.6T DK10186212T DK2269589T3 DK 2269589 T3 DK2269589 T3 DK 2269589T3 DK 10186212 T DK10186212 T DK 10186212T DK 2269589 T3 DK2269589 T3 DK 2269589T3
Authority
DK
Denmark
Prior art keywords
ion
binding polymers
hyperkalemia
applications
compositions
Prior art date
Application number
DK10186212.6T
Other languages
Danish (da)
English (en)
Inventor
Dominique Charmot
Gerrit Klaerner
Michael James Cope
Mingjun Liu
Futian Liu
Tony Kwok-Kong Mong
Han Ting Chang
Original Assignee
Relypsa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40774830&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2269589(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US10/813,872 external-priority patent/US8282960B2/en
Priority claimed from US10/814,527 external-priority patent/US7854924B2/en
Priority claimed from US10/814,749 external-priority patent/US8192758B2/en
Application filed by Relypsa Inc filed Critical Relypsa Inc
Application granted granted Critical
Publication of DK2269589T3 publication Critical patent/DK2269589T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F120/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F120/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F120/04—Acids; Metal salts or ammonium salts thereof
    • C08F120/06—Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F128/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a bond to sulfur or by a heterocyclic ring containing sulfur
    • C08F128/02—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a bond to sulfur or by a heterocyclic ring containing sulfur by a bond to sulfur

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Polymers & Plastics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Dental Preparations (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
DK10186212.6T 2004-03-30 2005-03-30 Ionbindende polymerer og anvendelser deraf DK2269589T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/813,872 US8282960B2 (en) 2004-03-30 2004-03-30 Ion binding compositions
US10/814,527 US7854924B2 (en) 2004-03-30 2004-03-30 Methods and compositions for treatment of ion imbalances
US10/814,749 US8192758B2 (en) 2004-03-30 2004-03-30 Ion binding compositions
US10/965,274 US7488495B2 (en) 2004-03-30 2004-10-13 Ion binding polymers and uses thereof
EP10152337A EP2184059B1 (fr) 2004-03-30 2005-03-30 Polymères de liaison potassique et leurs utilisations dans des methodes de traitement ou prophylaxie de l'hyperkaliémie

Publications (1)

Publication Number Publication Date
DK2269589T3 true DK2269589T3 (da) 2014-03-31

Family

ID=40774830

Family Applications (2)

Application Number Title Priority Date Filing Date
DK10186212.6T DK2269589T3 (da) 2004-03-30 2005-03-30 Ionbindende polymerer og anvendelser deraf
DK16203827.7T DK3219312T3 (en) 2004-03-30 2005-03-30 ION-BINDING POLYMERS AND THEIR APPLICATIONS

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK16203827.7T DK3219312T3 (en) 2004-03-30 2005-03-30 ION-BINDING POLYMERS AND THEIR APPLICATIONS

Country Status (14)

Country Link
EP (6) EP2269589B1 (fr)
JP (4) JP5600658B2 (fr)
KR (5) KR20130086262A (fr)
CN (2) CN102133196B (fr)
AT (2) ATE460927T1 (fr)
AU (5) AU2010214729B2 (fr)
CA (2) CA2829943C (fr)
DE (4) DE602005018619D1 (fr)
DK (2) DK2269589T3 (fr)
ES (6) ES2338667T3 (fr)
GB (2) GB2456253B (fr)
HK (2) HK1106133A1 (fr)
PL (3) PL3219312T3 (fr)
PT (3) PT2184059E (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2649462C2 (ru) 2012-07-11 2018-04-03 Конинклейке Филипс Н.В. Интерфейс пациента
CA2971725C (fr) * 2014-12-23 2024-05-14 Ardelyx, Inc. Compositions et methodes de traitement de l'hyperkaliemie
CN112291678B (zh) * 2020-04-03 2023-11-21 南京西觉硕信息科技有限公司 一种音频设备
US20240139234A1 (en) * 2021-11-17 2024-05-02 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Pharmaceutical polymer for treating hyperkalemia and preparation method thereof
CN117106852B (zh) * 2023-09-04 2024-03-19 济宁市兖州区检验检测中心 一种快速检测农产品农药残留的检测方法及其应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3031737A1 (de) 1980-08-22 1982-04-01 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von perlpolymerisaten einheitlicher teilchengroesse
US4675140A (en) 1984-05-18 1987-06-23 Washington University Technology Associates Method for coating particles or liquid droplets
CN1010098B (zh) * 1985-05-25 1990-10-24 赫彻斯特股份公司 α-氟代丙烯酸酯聚合物的制备方法
US4837015A (en) * 1987-03-05 1989-06-06 Carolina Medical Products Company, Inc. Alkali metal ion-charged, cation exchanger and use thereof to adjust sodium, potassium and calcium body fluid levels
FR2634377B1 (fr) * 1988-06-30 1991-09-27 Cortial Nouvelle forme pharmaceutique a liberation prolongee a base d'un complexe resine-principe actif
GB8829088D0 (en) 1988-12-13 1989-01-25 Smith Kline French Lab Compounds
US5236701A (en) 1989-07-19 1993-08-17 Lowchol Scientific Inc. Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol
DE3928990A1 (de) 1989-09-01 1991-03-07 Bayer Ag Verfahren zur herstellung von (alpha)-fluoroacrylsaeurederivaten
US5112993A (en) 1989-11-14 1992-05-12 E. I. Du Pont De Nemours And Company Process for the preparation of difluoromaleic anhydride
ATE116859T1 (de) * 1990-07-04 1995-01-15 Marcin Krotkiewski Blutdrucksenkendes präparat.
DE4139747A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Fuellstoffhaltige, optisch aktive perlpolymerisate
DK0684958T3 (da) 1993-02-17 1998-10-19 Btg Int Ltd Polymerer indeholdende guanidinogrupper til anvendelse i terapi
WO1994027619A1 (fr) * 1993-05-20 1994-12-08 Geltex Pharmaceuticals, Inc. Procede permettant d'ajuster la concentration ionique chez un patient et composition a cet effet
US5607669A (en) 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5496545A (en) 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
AU679708B2 (en) * 1993-11-25 1997-07-10 Salternate B.V. Particles for binding monovalent cations, use of such particles as well as methods for scavenging and removing sodium and/or potassium ions
WO1996021454A1 (fr) 1995-01-12 1996-07-18 Geltex Pharmaceuticals, Inc. Polymeres fixant les phosphates destines a etre administres par voie orale
GB9503061D0 (en) 1995-02-16 1995-04-05 British Tech Group Polymeric compounds
DE69705877T2 (de) 1996-03-05 2002-06-06 Mitsubishi Chemical Corp., Tokio/Tokyo Verwendung von Anionenaustauscherharzen zur Herstellung eines Arzneimittels zur Behandlung der Hyperphosphatemie
JP2000514791A (ja) * 1996-06-27 2000-11-07 ジー．ディー．サール アンド カンパニー 架橋した外殻領域および内部芯領域を有する両親媒性コポリマーからなり、医薬およびその他の用途に有用な粒子
CN1230118A (zh) 1996-07-19 1999-09-29 日研化学株式会社 高磷血症治疗剂
JP4358303B2 (ja) 1996-10-23 2009-11-04 ダウ グローバル テクノロジーズ インコーポレイティド 食物ホスフェート又はオキサレート吸収を低下させるための水溶性ポリマー
WO1998042355A1 (fr) 1997-03-25 1998-10-01 Geltex Pharmaceuticals, Inc. Polymeres liant le phosphate, combines a un supplement de calcium et administres par voie orale
US6423754B1 (en) 1997-06-18 2002-07-23 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with polyallylamine polymers
US5985938A (en) 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
US6475510B1 (en) 1997-12-19 2002-11-05 Smithkline Beecham Corporation Process for manufacturing bite-dispersion tablets
US6294163B1 (en) 1998-10-02 2001-09-25 Geltex Pharmaceuticals, Inc. Polymers containing guanidinium groups as bile acid sequestrants
EP1140037A1 (fr) * 1999-01-07 2001-10-10 ELAN CORPORATION, Plc Formes posologiques orale multiparticulaires
DE60027309T2 (de) 1999-07-02 2006-08-31 Symyx Technologies, Inc., Santa Clara Polymerverzweigungen zur immobilisierung von molekülen auf oberflächen oder substraten, wobei die polymere wasserlösliche oder wasserdispergierbare segmente und sonden aufweisen
ATE335826T1 (de) 1999-08-09 2006-09-15 Sandoz Ag Proteinherstellung
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
CN1202812C (zh) 1999-10-19 2005-05-25 基酶有限公司 直接压缩聚合物片剂核
EP1381376B1 (fr) 2000-11-20 2008-01-02 Sorbent Therapeutics, Inc. Polymeres hydroabsorbants et leur utilisation
ATE331525T1 (de) 2001-04-18 2006-07-15 Genzyme Corp Salzformarme polyallylamine
EP1429728A1 (fr) * 2001-08-29 2004-06-23 SRL Technologies, Inc. Preparations a liberation prolongee
JP4974882B2 (ja) * 2004-03-30 2012-07-11 レリプサ， インコーポレイテッド イオン結合ポリマーとその利用

Also Published As

Publication number Publication date
KR20130086262A (ko) 2013-07-31
ES2659386T3 (es) 2018-03-15
EP2184059B1 (fr) 2012-06-27
JP2012025783A (ja) 2012-02-09
EP2269589B1 (fr) 2013-12-25
EP2184059A2 (fr) 2010-05-12
KR20140003661A (ko) 2014-01-09
CN103251571B (zh) 2016-08-17
GB2456253A (en) 2009-07-15
HK1109338A1 (en) 2008-06-06
EP3219312A1 (fr) 2017-09-20
PL2184059T3 (pl) 2013-01-31
GB0906966D0 (en) 2009-06-03
AU2010214729B2 (en) 2012-08-16
AU2016216697C1 (en) 2019-03-21
PL2269589T3 (pl) 2014-05-30
KR20120130255A (ko) 2012-11-29
AU2018206706A1 (en) 2018-08-02
EP2269589A2 (fr) 2011-01-05
EP2158902A1 (fr) 2010-03-03
DE602005018619D1 (de) 2010-02-11
AU2018206706B2 (en) 2020-08-06
DK3219312T3 (en) 2019-04-01
JP5431439B2 (ja) 2014-03-05
CN103251571A (zh) 2013-08-21
KR20120060920A (ko) 2012-06-12
GB0907161D0 (en) 2009-06-10
EP2269590A2 (fr) 2011-01-05
GB2456253B (en) 2009-08-26
KR101362509B1 (ko) 2014-02-13
KR101223335B1 (ko) 2013-01-17
ES2453048T3 (es) 2014-04-03
JP2012031210A (ja) 2012-02-16
JP5600658B2 (ja) 2014-10-01
CN102133196B (zh) 2015-01-21
KR20110138300A (ko) 2011-12-26
AU2012254879A1 (en) 2012-12-13
ES2720612T3 (es) 2019-07-23
AU2016216697A1 (en) 2016-09-08
ES2339571T3 (es) 2010-05-21
EP3574896A1 (fr) 2019-12-04
CN102133196A (zh) 2011-07-27
GB2456256B (en) 2009-08-26
KR101269766B1 (ko) 2013-05-30
CA2829943A1 (fr) 2005-10-20
CA2806465C (fr) 2016-05-24
DE112005000708T5 (de) 2007-02-15
PT3219312T (pt) 2019-03-01
ES2338667T3 (es) 2010-05-11
EP2269589A3 (fr) 2011-10-05
DE112005000725T5 (de) 2007-05-03
JP5671511B2 (ja) 2015-02-18
DE112005000708B4 (de) 2017-12-21
CA2829943C (fr) 2017-03-14
PL3219312T3 (pl) 2019-07-31
PT2269589E (pt) 2014-02-26
AU2016216697B2 (en) 2018-04-19
DE112005000725B4 (de) 2017-12-21
GB2456256A (en) 2009-07-15
EP2269590A3 (fr) 2011-10-05
JP2014040484A (ja) 2014-03-06
CA2806465A1 (fr) 2005-10-20
AU2010214732B2 (en) 2012-07-12
EP2184059A3 (fr) 2010-05-19
ATE460927T1 (de) 2010-04-15
JP2013056909A (ja) 2013-03-28
ATE453383T1 (de) 2010-01-15
EP2158902B1 (fr) 2017-12-06
AU2010214729A1 (en) 2010-09-23
HK1106133A1 (en) 2008-03-07
AU2012254879B2 (en) 2016-05-19
EP3219312B1 (fr) 2019-01-30
PT2184059E (pt) 2012-07-06
AU2010214732A1 (en) 2010-09-23
KR101399238B1 (ko) 2014-05-27
ES2388052T3 (es) 2012-10-08
DE602005019992D1 (de) 2010-04-29

Similar Documents

Publication Publication Date Title
GB2430624B (en) Ion binding compositions
DE602005020501D1 (de) Vernetzte aminpolymere
WO2005092039A3 (fr) Polymeres amines reticules
GB2446076A (en) Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
GB2446077A (en) Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
NO20083973L (no) Farmasøytiske sammensetninger omfattende metylnaltrekson, kalsiumetylendiamintrieddiksyre og glycin.
NO20076413L (no) Multisykliske forbindelser og fremgangsmater for deres anvendelse
EA201000784A1 (ru) Антагонисты пути hedgehog и их терапевтические применения
DK3431094T3 (da) Tværbundne kationsbytningspolymerer, sammensætninger og anvendelse til behandling af hyperkaliæmi
WO2007038801A3 (fr) Compositions de liaison aux cations monovalents comprenant des particules coeur-ecorce avec des ecorces polyvinyliques reticulees et procedes pour les utiliser
CY1112980T1 (el) Φαρμακευτικες συνθεσεις, οι οποιες διαθετουν βελτιωμενα προφιλ διαλυσης για δυσδιαλυτες δραστικες ουσιες
WO2009114461A3 (fr) Formes pharmaceutiques d'angiotensine (1-7) et leur utilisation
DK2269589T3 (da) Ionbindende polymerer og anvendelser deraf
DK1622939T3 (da) Aktive varianter af det IL-18-bindende protein og medicinske anvendelser deraf
WO2009023544A3 (fr) Compositions pharmaceutiques à base de polymères échangeurs d'anions en dose
WO2008112325A3 (fr) Traitement de troubles auto-immuns
SE0300457D0 (sv) Novel compounds
WO2007123686A3 (fr) Inhibiteurs de la dipeptidyle peptidase (dpp) et leurs utilisations
WO2008070778A3 (fr) Pyridoxamine et héparinoïdes de masse moléculaire faible pour maladie rénale diabétique
WO2006116583A3 (fr) Compositions comprenant un benzimidazole polymerise et un tampon et procedes permettant de les utiliser
FR2879606B1 (fr) Dispersions aqueuses salines de (co)polymeres anioniques ou amphoteres, leur procede de fabrication et leurs applications